Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KYORIN Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Kyorin Acquires Production Facility from MSD 11
Partnerships 12
Kyorin Pharma Enters into Collaborative Agreement with Microbial Chemistry Research Foundation 12
Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 13
MSD Enters into Distribution Agreement with Kyorin Pharma 14
MSD Enters into Agreement with Kyorin Pharma 15
Kyorin Pharma to Enter into Co-Promotion Agreement with Kaken Pharma 16
Kissei Pharma Enters into Agreement with Kyorin Pharma 17
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 18
Kyorin Pharma Enters into Co-Marketing Agreement with Yoshida Pharma 19
Kyorin Pharma Amends Co-Marketing Agreement with MSD 20
Eisai Enters into Agreement with Kyorin 21
Kyorin Pharma Enters Into Research Agreement With BioLeap 22
Licensing Agreements 23
Kyorin Pharma Enters into Licensing Agreement with Sanwa Kagaku 23
KYORIN Rimedio Enters into a Licensing Agreement with Binh Dinh Pharma 24
Kyorin Pharma Enters into Licensing Agreement with Merck 25
Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 26
Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 27
Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 28
R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 29
Kyorin Pharma Enters into Licensing Agreement with Merck 30
Asset Transactions 31
Galderma Acquires Pekiron Cream From Kyorin Pharma 31
Acquisition 32
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 32
Teijin Acquires 10% Stake In Kyorin For US$197 Million 33
KYORIN Holdings Inc – Key Competitors 34
KYORIN Holdings Inc – Key Employees 35
KYORIN Holdings Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Other Significant Developments 37
Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 37
Feb 22, 2017: Kyorin Holdings: Establishment of a Representative Office in the Republic of Indonesia 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KYORIN Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KYORIN Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kyorin Acquires Production Facility from MSD 11
Kyorin Pharma Enters into Collaborative Agreement with Microbial Chemistry Research Foundation 12
Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 13
MSD Enters into Distribution Agreement with Kyorin Pharma 14
MSD Enters into Agreement with Kyorin Pharma 15
Kyorin Pharma to Enter into Co-Promotion Agreement with Kaken Pharma 16
Kissei Pharma Enters into Agreement with Kyorin Pharma 17
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 18
Kyorin Pharma Enters into Co-Marketing Agreement with Yoshida Pharma 19
Kyorin Pharma Amends Co-Marketing Agreement with MSD 20
Eisai Enters into Agreement with Kyorin 21
Kyorin Pharma Enters Into Research Agreement With BioLeap 22
Kyorin Pharma Enters into Licensing Agreement with Sanwa Kagaku 23
KYORIN Rimedio Enters into a Licensing Agreement with Binh Dinh Pharma 24
Kyorin Pharma Enters into Licensing Agreement with Merck 25
Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 26
Bristol-Myers Squibb Enters into Licensing Agreement with Kyorin Pharma 27
Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 28
R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 29
Kyorin Pharma Enters into Licensing Agreement with Merck 30
Galderma Acquires Pekiron Cream From Kyorin Pharma 31
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 32
Teijin Acquires 10% Stake In Kyorin For US$197 Million 33
KYORIN Holdings Inc, Key Competitors 34
KYORIN Holdings Inc, Key Employees 35
KYORIN Holdings Inc, Subsidiaries 36
List of Figures
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KYORIN Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8